LifeMine Therapeutics and GSK enter drug discovery and development alliance
The collaboration will utilize Avatar-Rx, LifeMine’s proprietary genomically-enabled drug discovery platform to access evolutionarily derived lead small molecules
The collaboration will utilize Avatar-Rx, LifeMine’s proprietary genomically-enabled drug discovery platform to access evolutionarily derived lead small molecules
The study was published recently in Genome Medicine, a leading international journal focused on translational, genomic-based medicine
This collaboration strengthens Akron’s portfolio of off-the-shelf gene-editing technologies while broadening Vor Bio’s collection of nucleases to engineer gene-modified cell therapies
All of Us Research Program releases genomic data to researchers, combined with participant-generated data collected on Vibrent Health’s research platform
The single in vitro diagnostic test helps inform therapy decisions according to clinical guidelines to enable precision medicine earlier in the disease journey
RNA, cell & gene therapies, artificial intelligence, CRISPR and oncology-related deals dominate the landscape
Most recently, Rollins was the Chief Information Officer at UnitedHealthcare
The Gujarat Biotechnology policy released last month has made radical changes to position the state as a biotechnology hub. It already has a thriving ecosystem of pharma companies and varied suppliers
Dr Ratna Puri from Sir Ganga Ram Hospital, Delhi is the Chairperson of the expert committee.
Dr. Bibikova is an international leader with over 25 years of experience in genomics industry
Subscribe To Our Newsletter & Stay Updated